Because Patients Matter
Make Better-Informed Decisions
Be Ready Against Hereditary Cancer
Helping Children Lead Better Lives

ESMO 2022 Myriad Symposium on Controversies in Breast & Ovarian Cancer, 12 September 2022

Join Myriad genetics at ESMO 2022 Industry Satellite Symposium on 12 September 2022 Read More

Sample Preparation and Requirements for myChoice HRD Webinar

Held on 12 July 2002 (Tuesday) from 3pm – 4pm, Read More

Are Surgeons Collecting Enough Tumor Tissue in Laparoscopic Biopsies for HRD Testing?

International Gynecologic Cancer Society (IGCS) Roundtable Webinar Held on 16 Read More

Let’s Talk Patient Aspects of Ovarian Cancer Treatment

The next Myriad Oncology webinar next Monday is focused on Read More

Psychedelics in Psychiatry

Join Genomind and guest speaker, Dr. Cody Wenthur, as we Read More

Cancer is a disease of abnormal gene function. Some gene changes that lead to cancer may be inherited. Breast, ovarian, prostate, and colon are some of these cancers that are linked to a family history. The genetic mutations that cause many of the known hereditary cancer syndromes have been identified, and genetic testing can confirm whether a condition is the result of an inherited syndrome. Genetic profiling may help you or other family members in planning health care for the future.

A companion diagnostic is a medical device which provides information that is essential for the safe and effective use of a corresponding drug. The test helps health care professionals identify patients who are most likely to benefit from a particular therapeutic product and patients who are likely to be at increased risk for serious side effects as a result of treatment. Companion diagnostics can also be used to monitor patient response to treatment for the purpose of adjusting treatment to achieve improved safety or effectiveness.

Rare genetic disorders can go undiagnosed for years. The lack of a diagnosis can have considerable adverse effects for patients and their families, including failure to identify potential treatments, failure to recognize risk of recurrence in subsequent pregnancies, and failure to provide anticipatory guidance and prognosis. Genetic testing has proven to be effective in detecting rare variants in an individual’s genome, offering hope to individuals with previously undiagnosed or untreated rare disorders.

Nearly 1 in 5 individuals suffer from mental illness. There are over 270 medications containing warnings, precautions and dosage recommendations based on specific gene variants. Two-thirds of patients will not achieve complete relief from their first medication.* Emerging science has allowed clinicians to use genetic tests to assist in the safe and appropriate selection of pharmacologic treatment for individuals suffering from mental illness, by unlocking unique insights to quickly identify a personalized treatment plan to help avoid the painful process of treatment by trial and error. *Based on the STAR*D Trial

Radiotherapy is a treatment where ionizing radiation is used to kill cancer cells and shrink tumours by damaging their DNA. Cancer cells whose DNA is damaged beyond repair stop dividing or dies, and they are broken down and removed by the body. Radiotherapy uses low energy ionizing radiation that avoids deep tissue damage an minimises scarring. This makes it superior in treating superficial tumours, and an excellent alternative to surgery for skin cancer in sensitive locations, such as the folds of the nose, eyelids or ears.

Enteric diseases are intestinal illness caused by micro-organisms such as viruses, bacteria and parasites. These diseases are most frequently acquired through contaminated food and water. Although enteric micro-organisms typically enter the body through the mouth, some can spread from person to person. Every year, millions of cases of foodborne illness occur in the United States, and the illness burden is even higher in developing countries.* Much of this burden could be prevented with better science and prevention tools. * Division of Foodborne, Waterborne, and Environmental Diseases – CDC.

Predictive, Preventive, and Personalized Medicine

Predictive, Preventive, and Personalized Medicine (PPPM) is the new integrative concept in healthcare that enables to predict individual predisposition before onset of the disease, to provide targeted preventive measures and create personalized treatment algorithms tailored to the person. PPPM offers great promise for the future practice of medicine resulting in substantial improvement of the quality of life.

ESMO 2022 Myriad Symposium on Controversies in Breast & Ovarian Cancer, 12 September 2022

Sample Preparation and Requirements for myChoice HRD Webinar

Are Surgeons Collecting Enough Tumor Tissue in Laparoscopic Biopsies for HRD Testing?

Let’s Talk Patient Aspects of Ovarian Cancer Treatment

Psychedelics in Psychiatry

Cancer

Companion Diagnostics

Unknown Genetic Disorders

Psychiatric Disorders

Predictive, Preventive, and Personalized Medicine